tiprankstipranks
Trending News
More News >
Advertisement
Advertisement

Lumos Diagnostics Seeks ASX Quotation for 5.2 Million New Shares

Story Highlights
  • Lumos Diagnostics has applied to quote 5.2 million new ordinary shares on the ASX.
  • The additional shares expand Lumos Diagnostics’ listed capital base and may improve trading liquidity.
  • Looking for the best stocks to buy? Follow the recommendations of top-performing analysts.
Lumos Diagnostics Seeks ASX Quotation for 5.2 Million New Shares

Claim 70% Off TipRanks Premium

Lumos Diagnostics Holdings Ltd. ( (AU:LDX) ) just unveiled an announcement.

Lumos Diagnostics Holdings Ltd. has applied to the ASX for quotation of 5,228,863 new ordinary fully paid shares, to be traded under its existing ticker LDX. The issuance of these additional securities, arising from the exercise or conversion of existing instruments, modestly expands the company’s listed share capital and may enhance liquidity for investors while signalling ongoing capital management activity.

The most recent analyst rating on (AU:LDX) stock is a Hold with a A$0.31 price target. To see the full list of analyst forecasts on Lumos Diagnostics Holdings Ltd. stock, see the AU:LDX Stock Forecast page.

More about Lumos Diagnostics Holdings Ltd.

Average Trading Volume: 4,566,001

Technical Sentiment Signal: Buy

Current Market Cap: A$216.5M

See more data about LDX stock on TipRanks’ Stock Analysis page.

Disclaimer & DisclosureReport an Issue

Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App
1